Multiple sclerosis (MS) is a chronic disease of the central nervous system (CNS). Onset typically occurs between the ages of 20 and 40 years. Evidence suggests that MS is an autoimmune disease that causes inflammation and damage in the central nervous system It is the most common disabling neurological disease of young adults.
African Americans are at higher risk of developing more severe episodes with quicker progression of the disease. African Americans have a greater risk of eventual disability as a result of the disease than Caucasian Americans. While Hispanic and Latino Americans have less risk of developing MS compared to Caucasian Americans, they may have a younger average age of onset with greater disease severity and faster progression.
Meridian is conducting a clinical research study for use of a medication in African Americans and Hispanic and Latino Americans aged 18 to 65 with MS.
Must be age 18 to 65
Must self-identify as African American, or Hispanic, or Latino American
Must have a diagnosis of relapsing multiple sclerosis at enrollment
May receive compensation for time and travel
Do not need insurance to join this study
For more information, complete the form on this page. After you submit your information, a Meridian enrollment specialist will call you to talk about the study. There is no obligation to join — you can decide if the study is right for you.
You can also talk to a Meridian enrollment specialist about this study by calling (757) 226-0655.
Submit your information
Meridian Clinical Research
6161 Kempsville Circle, Suite 315
Norfolk, VA 23502
After you submit your information, a Meridian enrollment specialist will contact you.
Participating in a study is an important decision — we’re here to help you before, during, and after studies.
Please note: Health insurance is NOT required to join.
Will I benefit from this study?
You are not guaranteed to benefit from being in a clinical study. However, information gathered in this study may help uncover better ways to treat condition(s) for you and others worldwide.
Is participation voluntary after I submit my information?
Yes. Participation in a study is entirely voluntary. In the informed consent process, you’ll learn about the product being studied, your role in the trial, potential side effects, tests that will be performed, and the number of visits required. You will need to sign an informed consent form to join the study only after you fully understand your role in the study.
Will I get a physical exam?
If you join the study, you will receive a physical exam. You may also receive specific exams or tests — the results of which will be shared with you.
Will I receive compensation?
While participation in a clinical study is voluntary, you may be reimbursed for your study-related travel and expenses. After you submit your information, a Meridian enrollment specialist will call you to talk about the study. Staff at the research clinic will discuss possible reimbursement with you.
Founded in 1999 in Omaha, NE, Meridian studies the safety and effectiveness of new medicines, devices, and treatments. Its mission is to enrich lives by providing quality, compassionate care to patients and unparalleled clinical research services. Clinical studies help scientists develop life-changing medicines, but it starts with you — participation makes it all possible. For more than 20 years, thousands of patients have trusted Meridian because of our focus on creating a positive patient experience.